Journal of Okayama Medical Association
Published by Okayama Medical Association

<Availability>
Full-text articles are available 3 years after publication.

An investigator initiated phase II clinical trial of tamibarotene (AM80G) for chronic graft-versus-host disease

Nishimori, Hisakazu Kaken ID researchmap
Maeda, Yoshinobu Kaken ID researchmap
127_133.pdf 1.63 MB
Published Date
2015-08-03
Keywords
臨床研究中核病院
慢性GVHD
タミバロテン
同種造血幹細胞移植
Th17
Note
特集(Feature Articles)
DOI
ISSN
0030-1558
NCID
AN00032489
NAID